Media

We strive to provide correct, relevant, balanced and clear information to shareholders, capital market, media and society, to facilitate understanding of our research, development and business operations.

Press release -

FDA approves Oncopeptides' PEPAXTO® ( melphalan flufenamide) for patients with relapsed or refractory multiple myeloma

Read press release

Image bank

Welcome to our image bank. Download pictures of our Management team, our board of directors & our logotype.

Image bank

Follow us on Social Media

linkedin.pngretweet.png

Oncopeptides via e-mail

Get our latest updates straight to your inbox. Unsubscribe at anytime.

This site is protected by reCAPTCHA & the Google Privacy Policy & Terms of Service  apply.